RLMD - Relmada Therapeutics GAAP EPS of -$0.84 March, 19 2024 04:22 PM Relmada Therapeutics Inc. 2024-03-19 16:22:18 ET More on Relmada Therapeutics Relmada: Phase 3 Data Did Not Live Up To Phase 2 Benchmark Seeking Alpha’s Quant Rating on Relmada Therapeutics Historical earnings data for Relmada Therapeutics Financial information for Relmada Therapeutics For further details see: Relmada Therapeutics GAAP EPS of -$0.84